Cynthia L Lucchese
CIK 1337319 · Senior Vice President & CFO · last filed 2026-05-11
Cynthia L Lucchese is a Senior Vice President & CFO who has filed 73 SEC Form 4 insider transactions across 8 companies since 2008. The most recent filing, for MOBI, was dated May 11, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.32M
8
73
-$2.80M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MOBI | Director | 125,000 | $11.45 | $1.43M | $1.88M | 1 | 2026-05-11 |
| COO | Director | 12,767 | $69.28 | $884.5K | $150.0K | 6 | 2026-04-06 |
| Inari Medical, Inc. (NARI) Delisted | Director | 0 | $79.97 | $0 | $533.7K | 7 | 2025-02-19 |
| HANGER, INC. (HNGR) Delisted | Director | 0 | $18.72 | $0 | $0 | 5 | 2022-10-04 |
| Intersect ENT, Inc. (XENT) Delisted | Director | 3,239 | $28.24 | $91.5K | $85.6K | 13 | 2022-05-16 |
| HANGER, INC. (HGR) Delisted | Director | 9,798 | — | — | $0 | 1 | 2015-11-20 |
| Hillenbrand, Inc. (HI) Delisted | Senior Vice President & CFO | 0 | $31.98 | $0 | -$5.52M | 34 | 2013-12-26 |
| BRIGHTPOINT INC (CELL) Delisted | Director | 0 | $1.00 | $0 | $71.5K | 3 | 2012-10-16 |
Recent Filings
73 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | MOBI | Mixed | +125,000 | $1.88M | EDGAR |
| 2026-04-06 | COO | Mixed | +3,322 | $0 | EDGAR |
| 2025-12-23 | COO | Buy (P) | +1,784 | $150.0K | EDGAR |
| 2025-04-03 | COO | Mixed | +2,721 | $0 | EDGAR |
| 2025-02-19 | Inari Medical, Inc. (NARI) Delisted | Mixed | −38,429 | $0 | EDGAR |
| 2024-05-31 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +4,126 | $175.0K | EDGAR |
| 2024-04-26 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +4,126 | $175.0K | EDGAR |
| 2024-04-03 | COO | Mixed | +2,892 | $0 | EDGAR |
| 2023-05-19 | Inari Medical, Inc. (NARI) Delisted | Grant (A) | +2,412 | $0 | EDGAR |
| 2023-04-03 | COO | Mixed | +512 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.